Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | JAZZ | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 265.00 | 27.96 | 237.78 | ||
| High | 269.35 | 28.18 | 241.82 | ||
| Low | 262.76 | 27.34 | 234.15 | ||
| Latest | 266.72 | 27.47 | 240.97 | ||
| Change | +3.02 | +1.45 | +3.25 | ||
| % Change | +1.15% | +5.57% | +1.37% | ||
| Volume | 630,500 | 2,573,500 | 1,000,800 | ||
| 20-Day Average Volume | 945,770 | 1,680,590 | 942,190 | ||
| Previous Close | 263.70 | 26.02 | 237.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 229.95 | 25.27 | 231.16 | ||
| 20-Day Raw Stochastic | 92.41% | 84.43% | 95.20% | ||
| 20-Day Relative Strength | 67.08 | 58.48 | 61.52 | ||
| Weighted Alpha | +54.60 | +22.08 | +111.04 | ||
| Today's Opinion | 72% Buy | 48% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 88% Sell | 100% Buy | ||
| Last Month's Opinion | 48% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.79% since 06/23/26 | +5.90% since 06/23/26 | +4.66% since 06/23/26 | ||
| Low | 235.51 on 06/25/26 | 25.33 on 06/26/26 | 224.95 on 06/25/26 | ||
| High | 271.89 on 06/25/26 | 28.18 on 06/30/26 | 241.82 on 06/30/26 | ||
| 1-Month | |||||
| %Chg | +19.01% since 05/29/26 | +4.33% since 05/29/26 | +1.89% since 05/29/26 | ||
| Low | 203.80 on 06/08/26 | 23.62 on 06/03/26 | 220.74 on 06/18/26 | ||
| High | 271.89 on 06/25/26 | 28.18 on 06/30/26 | 241.99 on 06/05/26 | ||
| 3-Month | |||||
| %Chg | +22.15% since 03/30/26 | +6.35% since 03/30/26 | +31.57% since 03/30/26 | ||
| Low | 203.80 on 06/08/26 | 23.62 on 06/03/26 | 184.18 on 04/06/26 | ||
| High | 271.89 on 06/25/26 | 29.43 on 04/14/26 | 243.32 on 05/22/26 | ||
| 6-Month | |||||
| %Chg | +27.41% since 12/30/25 | -12.77% since 12/30/25 | +41.07% since 12/30/25 | ||
| Low | 188.08 on 01/12/26 | 23.62 on 06/03/26 | 156.95 on 01/08/26 | ||
| High | 271.89 on 06/25/26 | 35.43 on 01/14/26 | 243.32 on 05/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,637,191 | 17,128,396 | 15,137,254 | ||
| Shares Outstanding, K | 62,377 | 623,531 | 62,818 | ||
| Annual Sales | 814,760,000 | 3,720,000,000 | 4,267,590,000 | ||
| Annual Net Income | -258,000,000 | 963,000,000 | -356,150,000 | ||
| Last Quarter Sales | 288,620,000 | 896,000,000 | 1,068,900,000 | ||
| Last Quarter Net Income | 736,580,000 | 53,000,000 | 293,100,000 | ||
| 60-Month Beta | 0.39 | 0.85 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.32 on 05/07/26 | 0.15 on 05/07/26 | 6.34 on 05/05/26 | ||
| Earnings Date | 08/06/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.72 | 26.01 | ||